Saint Vincent and the Grenadines vs Sur: Previously treated cases tested for RR-/MDR-TB
Saint Vincent and the Grenadines
100.0%
in 2022
Sur
62.0%
in 2024
Saint Vincent and the Grenadines rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Saint Vincent and the Grenadines
- Sur
How they compare
Saint Vincent and the Grenadines currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Saint Vincent and the Grenadines's figure about 1.6 times Sur's.
The two have swapped places 3 times across 5 shared years of data; in 2012 it was Sur ahead.
Saint Vincent and the Grenadines ranks 1st and Sur ranks 2nd of 180 countries.
Sur has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Vincent and the Grenadines | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 33.3% | 52.0% | 18.7% | Sur |
| 2020s | 50.0% | 84.0% | 34.0% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Saint Vincent and the Grenadines or Sur?
- Saint Vincent and the Grenadines, at 100.0% against 62.0% in Sur as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Saint Vincent and the Grenadines and Sur?
- 38.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Saint Vincent and the Grenadines and Sur?
- 5 years are reported by both, from 2012 to 2022.
- How do Saint Vincent and the Grenadines and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Saint Vincent and the Grenadines ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.